How have SNBIF shares performed in 2024?

SanBio's stock was trading at C$3.95 on January 1st, 2024. Since then, SNBIF shares have decreased by 2.5% and is now trading at C$3.85. View the best growth stocks for 2024 here .

How do I buy shares of SanBio?

Shares of SNBIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:SNBIF

SanBio (SNBIF) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free SNBIF Stock Alerts

C$3.85

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: C$3.85
▼
C$3.85
50-Day Range: C$3.80
▼
C$3.85
52-Week Range: C$3.80
▼
C$4.25

Volume: N/A
Average Volume: 325 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get SanBio alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About SanBio Stock (OTCMKTS:SNBIF)

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, Parkinson's disease, spinal cord injury, and Alzheimer's disease; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.

SNBIF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SNBIF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive SNBIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SanBio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:SNBIF
CUSIP: N/A
CIK: N/A
Web: www.sanbio.jp
Phone: 81 3 6264 3481
Fax: N/A
Employees: 65
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Toru Kawanishi (Age 57)
Co-Founder & Executive Chairman
Mr. Keita Mori MBA (Age 57)
Co-Founder, President, Executive Officer, CEO & Representative Director
Mr. Yoshihiro Kakutani
Corporate Officer of Management Administration
Mr. Greg Gillas
Senior Vice President of Human Resources & Corporate Services
Mr. Naoki Tsukahara
Senior Corporate Officer
Dr. Kazumi Sawaguchi Ph.D.
Corporate Officer and Head of Japan Regulatory Affairs & Quality Compliance Japan
Mr. Keizo Nakada
Corporate Officer & Head of Production
Shinya Hirata
Corporate Officer & Head of Research and Development
Mr. Dai Chida
Senior Scientific Advisor
Masumi Akahori
In charge of IR

Key Competitors

View All Competitors

SNBIF Stock Analysis - Frequently Asked Questions

How have SNBIF shares performed in 2024?: SanBio's stock was trading at C$3.95 on January 1st, 2024. Since then, SNBIF shares have decreased by 2.5% and is now trading at C$3.85.
View the best growth stocks for 2024 here.
How do I buy shares of SanBio?: Shares of SNBIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SNBIF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial